Philippe Lenoble
Vorsitzender bei Ducentis BioTherapeutics Ltd.
Profil
Philippe Lenoble is currently the Chairman at Ducentis BioTherapeutics Ltd., Director at Sintonia SpA, and Director at CFA Society of the UK.
He previously worked as a Research Assistant at Université Catholique de Louvain.
He completed his undergraduate degree at Université Catholique de Louvain.
Aktive Positionen von Philippe Lenoble
| Unternehmen | Position | Beginn |
|---|---|---|
Sintonia SpA
 Sintonia SpA Investment ManagersFinance Sintonia SA operates as an investment holding company with interests in the infrastructure sector and mobility services. The company is headquartered in Treviso, Italy. | Direktor/Vorstandsmitglied | - |
Ducentis BioTherapeutics Ltd.
 Ducentis BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Ducentis Biotherapeutics Ltd. develops novel therapies for inflammation and autoimmune disease. The company was founded by Rebecca Ashfield, David Blackbourn and Philip Huxley in March 2015 and is headquartered in Witney, the United Kingdom. | Vorsitzender | - |
CFA Society of the UK
 CFA Society of the UK Miscellaneous Commercial ServicesCommercial Services CFA Society of the UK is an association of investment professionals based in the UK. The British company was founded in an unspecified year. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Philippe Lenoble
| Unternehmen | Position | Ende |
|---|---|---|
| Université Catholique de Louvain | Corporate Officer/Principal | - |
Ausbildung von Philippe Lenoble
| Université Catholique de Louvain | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Sintonia SpA
Sintonia SpA Investment ManagersFinance Sintonia SA operates as an investment holding company with interests in the infrastructure sector and mobility services. The company is headquartered in Treviso, Italy. | Finance |
Ducentis BioTherapeutics Ltd.
Ducentis BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Ducentis Biotherapeutics Ltd. develops novel therapies for inflammation and autoimmune disease. The company was founded by Rebecca Ashfield, David Blackbourn and Philip Huxley in March 2015 and is headquartered in Witney, the United Kingdom. | Health Technology |
CFA Society of the UK
CFA Society of the UK Miscellaneous Commercial ServicesCommercial Services CFA Society of the UK is an association of investment professionals based in the UK. The British company was founded in an unspecified year. | Commercial Services |
